Published in Sci Rep on February 10, 2016
Basic local alignment search tool. J Mol Biol (1990) 659.07
KEGG: kyoto encyclopedia of genes and genomes. Nucleic Acids Res (2000) 117.00
An integrated map of genetic variation from 1,092 human genomes. Nature (2012) 59.82
ANNOVAR: functional annotation of genetic variants from high-throughput sequencing data. Nucleic Acids Res (2010) 43.51
Multiple sequence alignment with the Clustal series of programs. Nucleic Acids Res (2003) 38.75
Jalview Version 2--a multiple sequence alignment editor and analysis workbench. Bioinformatics (2009) 31.84
The Cancer Cell Line Encyclopedia enables predictive modelling of anticancer drug sensitivity. Nature (2012) 31.78
COSMIC: mining complete cancer genomes in the Catalogue of Somatic Mutations in Cancer. Nucleic Acids Res (2010) 25.55
Pfam: the protein families database. Nucleic Acids Res (2013) 22.48
An inhibitor of Bcl-2 family proteins induces regression of solid tumours. Nature (2005) 22.40
Apoptosis: a review of programmed cell death. Toxicol Pathol (2007) 17.92
Systematic identification of genomic markers of drug sensitivity in cancer cells. Nature (2012) 15.91
Accelerated Profile HMM Searches. PLoS Comput Biol (2011) 15.22
HMMER web server: interactive sequence similarity searching. Nucleic Acids Res (2011) 13.00
ABT-199, a potent and selective BCL-2 inhibitor, achieves antitumor activity while sparing platelets. Nat Med (2013) 8.89
Apoptosis: a link between cancer genetics and chemotherapy. Cell (2002) 7.86
HHblits: lightning-fast iterative protein sequence searching by HMM-HMM alignment. Nat Methods (2011) 6.06
Comparative protein structure modeling using MODELLER. Curr Protoc Protein Sci (2007) 5.81
Interferon-alpha induction through Toll-like receptors involves a direct interaction of IRF7 with MyD88 and TRAF6. Nat Immunol (2004) 5.71
Apoptosis in cancer. Carcinogenesis (2000) 5.49
Predicting the functional, molecular, and phenotypic consequences of amino acid substitutions using hidden Markov models. Hum Mutat (2012) 3.60
Bcl-2 family proteins and cancer. Oncogene (2008) 3.42
BCL-2 family antagonists for cancer therapy. Nat Rev Drug Discov (2008) 3.24
Apoptosis in cancer: from pathogenesis to treatment. J Exp Clin Cancer Res (2011) 3.18
SUPERFAMILY--sophisticated comparative genomics, data mining, visualization and phylogeny. Nucleic Acids Res (2008) 3.07
A map of human cancer signaling. Mol Syst Biol (2007) 2.50
Apoptosis defects and chemotherapy resistance: molecular interaction maps and networks. Oncogene (2004) 2.36
A community effort to assess and improve drug sensitivity prediction algorithms. Nat Biotechnol (2014) 2.12
Down-regulation of caspase 3 in breast cancer: a possible mechanism for chemoresistance. Oncogene (2002) 2.03
Recent advances in apoptosis, mitochondria and drug resistance in cancer cells. Biochim Biophys Acta (2011) 2.00
Downregulation of Smac/DIABLO expression in renal cell carcinoma and its prognostic significance. J Clin Oncol (2004) 1.73
DbPTM 3.0: an informative resource for investigating substrate site specificity and functional association of protein post-translational modifications. Nucleic Acids Res (2012) 1.71
Discrepancies in cancer genomic sequencing highlight opportunities for driver mutation discovery. Cancer Res (2014) 1.70
Integrative analysis of proteomic signatures, mutations, and drug responsiveness in the NCI 60 cancer cell line set. Mol Cancer Ther (2010) 1.62
Birinapant (TL32711), a bivalent SMAC mimetic, targets TRAF2-associated cIAPs, abrogates TNF-induced NF-κB activation, and is active in patient-derived xenograft models. Mol Cancer Ther (2014) 1.42
Predictive genomics: a cancer hallmark network framework for predicting tumor clinical phenotypes using genome sequencing data. Semin Cancer Biol (2014) 1.40
Loss of caspase-1 and caspase-3 protein expression in human prostate cancer. Cancer Res (2001) 1.35
Smac mimetics as new cancer therapeutics. Anticancer Drugs (2009) 1.32
VariBench: a benchmark database for variations. Hum Mutat (2012) 1.31
Overcoming drug resistance by enhancing apoptosis of tumor cells. Curr Cancer Drug Targets (2009) 1.26
How cells die: apoptosis pathways. J Allergy Clin Immunol (2001) 1.24
Signaling network assessment of mutations and copy number variations predict breast cancer subtype-specific drug targets. Cell Rep (2013) 1.21
Profiles of Basal and stimulated receptor signaling networks predict drug response in breast cancer lines. Sci Signal (2013) 1.17
Small changes huge impact: the role of protein posttranslational modifications in cellular homeostasis and disease. J Amino Acids (2011) 1.12
Toll-Like Receptors and Cancer: MYD88 Mutation and Inflammation. Front Immunol (2014) 1.10
COLT-Cancer: functional genetic screening resource for essential genes in human cancer cell lines. Nucleic Acids Res (2011) 1.08
Design of small-molecule Smac mimetics as IAP antagonists. Curr Top Microbiol Immunol (2011) 1.06
Increased expression of inhibitor of apoptosis proteins, survivin and XIAP, in non-small cell lung carcinoma. Int J Oncol (2009) 1.05
DeathBase: a database on structure, evolution and function of proteins involved in apoptosis and other forms of cell death. Cell Death Differ (2010) 1.04
Role of XIAP in the malignant phenotype of transitional cell cancer (TCC) and therapeutic activity of XIAP antisense oligonucleotides against multidrug-resistant TCC in vitro. Int J Cancer (2003) 1.01
AT-406, an orally active antagonist of multiple inhibitor of apoptosis proteins, inhibits progression of human ovarian cancer. Cancer Biol Ther (2012) 1.01
Role of Smac/DIABLO in cancer progression. J Exp Clin Cancer Res (2008) 1.00
Differential expression of cell cycle and apoptosis related proteins in colorectal mucosa, primary colon tumours, and liver metastases. J Clin Pathol (2002) 0.98
Deregulation of apoptosis in acute myeloid leukemia. Haematologica (2007) 0.96
Clinical significance of Smac/DIABLO expression in colorectal cancer. Oncol Rep (2009) 0.95
Targeted therapy of the XIAP/proteasome pathway overcomes TRAIL-resistance in carcinoma by switching apoptosis signaling to a Bax/Bak-independent 'type I' mode. Cell Death Dis (2013) 0.92
Post-translational modification of cellular proteins by ubiquitin and ubiquitin-like molecules: role in cellular senescence and aging. Adv Exp Med Biol (2010) 0.86
Caspase-2 impacts lung tumorigenesis and chemotherapy response in vivo. Cell Death Differ (2014) 0.84
XIAP expression is associated with pancreatic carcinoma outcome. Mol Clin Oncol (2013) 0.81
Deregulation of cell death (apoptosis): implications for tumor development. Discov Med (2009) 0.78
CancerDR: cancer drug resistance database. Sci Rep (2013) 0.96
PCMdb: pancreatic cancer methylation database. Sci Rep (2014) 0.90
A Platform for Designing Genome-Based Personalized Immunotherapy or Vaccine against Cancer. PLoS One (2016) 0.78
Designing of promiscuous inhibitors against pancreatic cancer cell lines. Sci Rep (2014) 0.78
dbEM: A database of epigenetic modifiers curated from cancerous and normal genomes. Sci Rep (2016) 0.77
An in silico platform for predicting, screening and designing of antihypertensive peptides. Sci Rep (2015) 0.75